Home › Funds › Point72 Asset Management › ROIV
Point72 Asset Management position in ROIV
ROIVANT SCIENCES LTD · Health Care
Latest position (Q2 2026)4.50M sh
Reported value held$159.11M
Portfolio Weight0.18%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 877.00K | $3.57M | New |
| Q4 2022 | 576.80K | $4.61M | New |
| Q3 2023 | 2.71M | $31.61M | New |
| Q4 2023 | 433.70K | $4.87M | Reduce |
| Q1 2024 | 461.90K | $4.87M | Add |
| Q2 2024 | 647.13K | $6.84M | Add |
| Q1 2025 | 614.32K | $6.20M | New |
| Q2 2025 | 2.95M | $33.26M | Add |
| Q3 2025 | 3.06M | $46.27M | Add |
| Q4 2025 | 101.60K | $2.20M | Reduce |
| Q1 2026 | 975.00K | $27.01M | Add |
| Q2 2026 | 4.50M | $159.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ROIV
- Fidelity Management & Research (FMR) 81.02M sh · $2.87B · Q2 2026
- BlackRock Inc 48.24M sh · $1.71B · Q2 2026
- Morgan Stanley 42.59M sh · $1.51B · Q2 2026
- Vanguard Group 42.06M sh · $912.68M · Q4 2025
- Goldman Sachs Group 18.56M sh · $656.71M · Q2 2026
- UBS Group AG 17.47M sh · $618.14M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- Geode Capital Management 11.67M sh · $425.54M · Q2 2026
- Wells Fargo & Co 9.72M sh · $344.04M · Q2 2026
- Invesco Ltd 7.53M sh · $266.53M · Q2 2026
- AQR Capital Management 6.63M sh · $234.03M · Q2 2026
- Viking Global Investors 6.27M sh · $221.95M · Q2 2026